Global Information
회사소개 | 문의

구강 점막 흡수형 약물 전달 : 제품, 기업, 시장 및 예측

Oral Transmucosal Drug Delivery to 2018: Products, Players, Markets & Forecasts

리서치사 Greystone Research Associates
발행일 2014년 05월 상품 코드 242925
페이지 정보 영문
US $ 2,850 ₩ 3,245,000 PDF by E-mail (Single User License)
US $ 4,500 ₩ 5,125,000 PDF by E-mail (Site License)
US $ 6,500 ₩ 7,402,000 PDF by E-mail (Global License)

구강 점막 흡수형 약물 전달 : 제품, 기업, 시장 및 예측 Oral Transmucosal Drug Delivery to 2018: Products, Players, Markets & Forecasts
발행일 : 2014년 05월 페이지 정보 : 영문

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

구강 점막 흡수형 약물 전달(Oral Transmucosal Drug Delivery) 시장에 대해 종합적으로 조사하고, 구강 점막 흡수형 약물 전달 기술 및 시장에 미치는 영향 분석과 평가, 구강 점막 흡수형 약제와 파이프라인 후보의약품 분석, 주요 구강 점막 흡수형 약제의 치료 분류 평가, 시장 데이터 및 예측, 시장 진출 기업 개요와 제품 개발 활동·전략 등의 정보를 전해드립니다.

1. 주요 요약

2. 약물 전달 시장 역학

  • 약제 개발의 발전
  • 시장 및 수요 촉진요인
  • 경쟁 구도

3. 점막 흡수형 전달 기술의 경쟁

  • 구강 스프레이
  • 구강 필름 및 정제
  • 설하 필름 및 웨이퍼

4. 시판 구강 점막 흡수 제제 플랫폼

5. 구강 점막 흡수형 약제의 기술 요인

  • 흡수
  • 생물학적 이용가능성(Bioavailability)
  • 부착력
  • 약물동태학(Pharmacokinetics)

6. FDA 인가완료 구강 점막 흡수형 제품

  • 아드레날린 억제제
  • 항진균제
  • GABA 작용제
  • 호르몬
  • 질산염
  • 오피오이드 작용제
  • 향정신성 약물
  • 세라토닌 5-HT3 억제제

7. 중요 파이프라인 후보의약품

8. 시장 평가 및 예측

  • 약물중독
  • 항감염약
  • 심장병
  • 당뇨병
  • 면역계
  • 감염증
  • 신경과
  • 종양
  • 통증 관리
  • 성 건강
  • 백신

9. 시장 요인

  • 제제 및 전용 플랫폼
  • 정부 규제 특허
  • 특허 만료 및 Rx(처방약)에서 OTC(시판약)으로의 전환

10. 기업 개요

KSM 14.05.12

In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. Growth in this sector will be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.


  • Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market
  • Analyzes oral transmucosal drug products and pipeline product candidates
  • Provides assessments of key oral transmucosal drug therapeutic categories
  • Provides market data and forecasts to 2018
  • Profiles market participants, their product development activities and strategies

What You Will Learn

  • What are the key segments and patient demographics that comprise the market for oral transmucosal drug delivery?
  • What are the major therapeutic demand drivers for transmucosal drug products?
  • What are the design factors and technologies that are being used in commercial and development-stage transmucosal products?
  • What is the market share and product position in the market and what will it look like in 2018?
  • Who are the companies behind the current generation of transmucosal drugs and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging transmucosal products?
  • What is the impact of economic, technology, and regulatory factors?

Table of Contents

Executive Summary

Drug Delivery Market Dynamics

  • Evolution in Drug Development
  • Market and Demand Drivers
    • Shifting Patient Demographics
    • The Impact of Generics
    • Managed Care Initiatives
  • Competitive Landscape

Competing Transmucosal Delivery Technologies

  • Oral Sprays
  • Buccal Films and Tablets
  • Sublingual Films and Wafers

Commercial Transmucosal Formulation Platforms

Oral Transmucosal Drug Technology Factors

  • Absorption
  • Bioavailability
  • Adhesion
  • Pharmacokinetics

FDA-Approved Oral Transmucosal Products

  • Andrenergic Inhibitors
  • Antifungals
  • GABA Agonists
  • Hormones
  • Nitrates
  • Opioid Agonists
  • Psychotropic Agents
  • Serotonin 5-HT3 Inhibitors

Important Pipeline Product Candidates

Market Assessments & Forecasts

  • Addiction
  • Anti-infectives
  • Cardiology
  • Diabetes
  • Immunology
  • Infectious Disease
  • Neurology
  • Oncology
  • Pain Management
  • Sexual Health
  • Vaccines

Market Factors

  • Formulations and Proprietary Platforms
  • Government Regulations Patent
  • Expiration and Rx-to-OTC Switching

Market Participant Profiles

Back to Top
전화 문의
BCC Research